PuSH - Publikationsserver des Helmholtz Zentrums München

Tan, H.* ; Su, W.* ; Zhang, W.* ; Zhang, J.* ; Sattler, M. ; Zou, P.

Albumin-binding domain extends half-life of glucagon-like peptide-1.

Eur. J. Pharmacol. 890:173650 (2021)
Postprint DOI Verlagsversion bestellen
Open Access Green
Glucagon-like peptide-1 (GLP-1) is considered to be a promising peptide for the treatment of type 2 diabetes mellitus (T2DM). However, the extremely short half-life of GLP-1 limits its clinical application. Albumin-binding domain (ABD) with high affinity for human serum albumin (HSA) has been used widely for half-life extension of therapeutic peptides and proteins. In the present study, novel GLP-1 receptor agonists were designed by genetic fusion of GLP-1 to three kinds of ABDs with different affinities for HSA: GA3, ABD035 and ABDCon. The bioactivities and half-lives of ABD-fusion GLP-1 proteins with different types and lengths of linkers were investigated in vitro and in vivo. The results demonstrated that ABD-fusion GLP-1 proteins could bind to HSA with high affinity. The blood glucose-lowering effect of GLP-1 was significantly improved and sustained by fusion to ABD. Meanwhile, the fusion proteins significantly inhibited food intake, which was beneficial for T2DM and obesity treatment. The half-life of GLP-1 was substantially extended by virtue of ABD. The in vivo results also showed that a longer linker inserted between GLP-1 and ABD resulted in a higher blood glucose-lowering effect. The fusion proteins generated by fusion of GLP-1 to GA3, ABD035 and ABDCon exhibited similar bioactivities and pharmacokinetics in vivo. These findings demonstrate that ABD-fusion GLP-1 proteins retain the bioactivities of natural GLP-1 and can be further developed for T2DM treatment and weight loss. It also indicates that the ABD-fusion strategy can be generally applicable to any peptide or protein, to improve pharmacodynamic and pharmacokinetic properties.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Abd035 ; Abdcon ; Bioactivity ; Ga3 ; Glucagon-like Peptide-1 ; Half-life Extension; Antibody Fusion Protein; Single-chain Diabody; Affinity; Liraglutide; Expression; Platform; Linkers; Obesity; Design; Glp-1
ISSN (print) / ISBN 0014-2999
e-ISSN 0014-2999
Quellenangaben Band: 890, Heft: , Seiten: , Artikelnummer: 173650 Supplement: ,
Verlag Elsevier
Verlagsort Radarweg 29, 1043 Nx Amsterdam, Netherlands
Begutachtungsstatus Peer reviewed
Förderungen Youth Innovation Promotion Association, Chinese Academy of Sciences
National Natural Science Foundation of China